Publication | Closed Access

Efficient utilization of the reduced folate carrier in CCRF-CEM human leukemic lymphoblasts by the potent antifolate Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine (PT523) and its B-ring analogues

Hematological MalignancyReduced Folate CarrierMedicinePotent Antifolate Nα-Anti-cancer AgentPharmacologyRadiation OncologyB-ring AnaloguesDrug Discovery